loading...| Preferred Name |
baricitinib |
| Synonyms |
LY-3009104 |
| ID |
http://purl.bioontology.org/ontology/MESH/C000596027 |
| altLabel |
LY-3009104 INCB028050 baricitinib phosphate salt INCB-28050 3-azetidineacetonitrile, 1-(ethylsulfonyl)-3-(4-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)-1H-pyrazol-1-yl)- 3-azetidineacetonitrile, 1-(ethylsulfonyl)-3-(4-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)-1H-pyrazol-1-yl)-, phosphate (1:1) INCB-028050 Olumiant LY3009104 baricitinib phosphate |
| cui |
C5564758 C4045874 C4044947 C4045875 C5691113 C4694844 |
| HM |
D013449 D001384 D011687 D011720 |
| Inverse of RB |
ISP4442I3Y 0 XIB47S8NNB |
| LT |
TRD |
| Mapped to |
http://purl.bioontology.org/ontology/MESH/D011687 http://purl.bioontology.org/ontology/MESH/D001384 |
| MDA |
20150315 |
| MeSH Frequency |
467 |
| MMR |
20220228 |
| notation |
C000596027 |
| prefLabel |
baricitinib |
| RR |
XIB47S8NNB |
| SC |
1 |
| Scope Statement |
inhibits Janus kinases JAK1 and JAK2 |
| SRC |
Expert Opin Investig Drugs. 2014 Aug;23(8):1067-77. |
| TERMUI |
T001109350 T001109347 T001109351 T000876835 T000993797 T001109348 T001109345 T000876833 T001109349 T000876834 T001109346 |
| TH |
FDA SRS (2015) NLM (2015) FDA SRS (2017) USAN (19XX) INN (19XX) NLM (2020) |
| tui |
T109 T121 |